FMT occupies a unique regulatory space. Click here for information about:
• Who we work with
• FMT and the FDA
OpenBiome provides frozen, pre-screened, ready-to-use microbiota preparations for FMT in three different formats. Click here for information about:
• Treatment Formats
• Storage Information
• Material Tracking and Data Reporting Requirements
• Billing and Coding
Place an Order
Over 600 healthcare institutions across all 50 U.S. states and 6 countries have joined our clinical network. Click here to learn more about:
• Joining the OpenBiome Clinical Network
• Ordering Material
• Shipping Information
OpenBiome was founded to make offering FMT easier, safer, and less expensive for clinicians. Click here for more information about:
• Delivery Modality
• Patient Preparation
• Material Preparation
• Patient Discharge and Follow-Up
Quality and Safety
The OpenBiome Quality and Safety Program governs our operations from donor assessment through stool processing, monitoring controls, and continuous improvement. Click here to learn more about:
• Quality and Safety Program
• Monitoring and Traceability
Forms and Guides
This section serves as a one-stop-shop for the important forms and resources at your disposal when you work with our material. Whether you're a new clinician interested in joining our network or a long-term partner who would like to provide educational material for your patients, you will find all of the resources you should need here.
Nearly half a million Americans are infected withC. difficile each year. About 1 in 5 do not respond to antibiotics, but a treatment called Fecal Microbiota Transplantation (FMT) has been shown to be a promising new therapy. Read more about how OpenBiome is working to expand access to FMT for patients suffering from recurrent C. difficile infections.
The human microbiome presents a new frontier in biomedical research, and current evidence suggests that the microbiome plays an influential role in not only C. difficile infection, but also in many aspects of human health and disease. Read moreabout how OpenBiome is facilitating research efforts by developing a new set of tools and services.
Why We're Here
We founded OpenBiome, a nonprofit 501(c)(3) organization, after watching a friend and family member suffer through 18 months of C. difficile and 7 rounds of vancomycin before finally receiving a successful, life-changing FMT. The remarkable efficacy of this treatment and the great lengths required to receive it convinced us that we needed to help expand access.
We work with clinicians to make Fecal Microbiota Transplantation (FMT) easier, cheaper, safer and more widely available. We do so by providing hospitals with screened, frozen material ready for clinical use. This service eliminates the time, staff, protocols, and facilities needed to screen and prepare material from new donors for each treatment.